Floatz logo

GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM

G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim

Asan Medical Centerprotein_peptidePhase 3Dormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

498 Active assets in the G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Jonsson Comprehensive Cancer Center
Phase 4BBB
Inno-206
University of Arkansas
Phase 3BBB
Hyaluronidase fihj
Massachusetts General Hospital
Phase 4BBB
Busulphan
M.D. Anderson Cancer Center
Phase 4BBB
Filanesib
PETHEMA Foundation
Phase 2BBB

View all 50 →

Same molecule, other indications

GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM is also rated in:

neoplasmDormant
BB
Indicative ·
69 / 100
View asset →
DLBCLDormant
BB
Indicative ·
68 / 100
View asset →
Hodgkin DiseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →